Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06402877
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2024-05-03
Brief Title:
Evaluation of Salivary Adseverin 1-Alpha Defensin and sRANKL Levels of Individuals With Different Periodontal Diseases
Sponsor:
Izmir Katip Celebi University
Organization:
Izmir Katip Celebi University
Study Overview
Official Title:
Assessment of Saliva Adseverin1-Alpha Defensin and sRANKL Soluble RANKL Levels In Individuals With Different Periodontal Diseases
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is detection of Adseverin1-alpha DefensinsRANKLsoluble RANKL levels in saliva samples of periodontally healthy gingivitis and periodontitis patients and the possible correlation between these values and clinical parameters of periodontal diseases Materials and methods Samples of saliva were obtained from 60 systemically healthy non-smoker individuals with periodontitis P n20 gingivitisG n20 and healthy periodontium S n20 Full-mouth clinical periodontal measurements including probing depth PD clinical attachment level CAL bleeding on probing BOP gingival index GI and plaque index PI were also recorded Enzyme-linked immunosorbent assay ELISA was used to determine Adseverin1-alpha DefensinsRANKLsoluble RANKL levels in the biological samples
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None